Please use this identifier to cite or link to this item: https://doi.org/10.3389/fimmu.2020.553362
DC FieldValue
dc.titleHumanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics
dc.contributor.authorYong, K.S.M.
dc.contributor.authorHer, Z.
dc.contributor.authorTan, S.Y.
dc.contributor.authorTan, W.W.S.
dc.contributor.authorLiu, M.
dc.contributor.authorLai, F.
dc.contributor.authorHeng, S.M.
dc.contributor.authorFan, Y.
dc.contributor.authorChang, K.T.E.
dc.contributor.authorWang, C.-I.
dc.contributor.authorChan, J.K.Y.
dc.contributor.authorChen, J.
dc.contributor.authorChen, Q.
dc.date.accessioned2021-08-25T14:22:28Z
dc.date.available2021-08-25T14:22:28Z
dc.date.issued2020
dc.identifier.citationYong, K.S.M., Her, Z., Tan, S.Y., Tan, W.W.S., Liu, M., Lai, F., Heng, S.M., Fan, Y., Chang, K.T.E., Wang, C.-I., Chan, J.K.Y., Chen, J., Chen, Q. (2020). Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics. Frontiers in Immunology 11 : 553362. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2020.553362
dc.identifier.issn16643224
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/199445
dc.description.abstractAdvancements in science enable researchers to constantly innovate and create novel biologics. However, the use of non-human animal models during the development of biologics impedes identification of precise in vivo interactions between the human immune system and treatments. Due to lack of this understanding, adverse effects are frequently observed in healthy volunteers and patients exposed to potential biologics during clinical trials. In this study, we evaluated and compared the effects of known immunotoxic biologics, Proleukin®/IL-2 and OKT3 in humanized mice (reconstituted with human fetal cells) to published clinical outcomes. We demonstrated that humanized mice were able to recapitulate in vivo pathological changes and human-specific immune responses, such as elevated cytokine levels and modulated lymphocytes and myeloid subsets. Given the high similarities of immunological side effects observed between humanized mice and clinical studies, this model could be used to assess immunotoxicity of biologics at a pre-clinical stage, without placing research participants and/or patients at risk. © Copyright © 2020 Yong, Her, Tan, Tan, Liu, Lai, Heng, Fan, Chang, Wang, Chan, Chen and Chen.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2020
dc.subjectbiologic testing
dc.subjectcytokine storm
dc.subjecthumanized mice
dc.subjectimmunotoxicity
dc.subjectinflammation
dc.typeArticle
dc.contributor.departmentDEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.description.doi10.3389/fimmu.2020.553362
dc.description.sourcetitleFrontiers in Immunology
dc.description.volume11
dc.description.page553362
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fimmu_2020_553362.pdf1.96 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons